Neonatal Lupus: What We Have Learned and Current Approaches to Care.

about

Critical updates in the 7th edition of the American Society for Apheresis guidelines.Neonatal Systemic Lupus Erythematosus Syndrome: a Comprehensive Review.

P2860

Q48217985-CE288149-FB74-4B6B-9B81-2B6A93F0AF1D Q50108711-65C072B6-6B3A-4855-8492-9C9B66FC43F3

P2860

Neonatal Lupus: What We Have Learned and Current Approaches to Care.

Item

http://www.wikidata.org/entity/Q38836068

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Neonatal Lupus: What We Have Learned and Current Approaches to Care.

@en

type

Item

label

Neonatal Lupus: What We Have Learned and Current Approaches to Care.

@en

prefLabel

Neonatal Lupus: What We Have Learned and Current Approaches to Care.

@en

P1476

Neonatal Lupus: What We Have Learned and Current Approaches to Care.

@en

P2093

Marisa S Klein-Gitelman

http://www.w3.org/2001/XMLSchema#string

P2860

Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease

Hydroxychloroquine in lupus pregnancy.

Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry.

Congenital heart block maternal sera autoantibodies target an extracellular epitope on the α1G T-type calcium channel in human fetal hearts.

Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.

Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.

Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.

Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.

Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus

Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.

P2888

s11926-016-0610-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11926-016-0610-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039771080

http://www.w3.org/2001/XMLSchema#string

P698

27475948

http://www.w3.org/2001/XMLSchema#string

Neonatal Lupus: What We Have Learned and Current Approaches to Care.

about

P2860

P2860

Neonatal Lupus: What We Have Learned and Current Approaches to Care.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698